Cargando…

Correction: Predicting Tumor Responses to Gefitinib and Erlotinib

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313822/
http://dx.doi.org/10.1371/annotation/d3542745-d656-445b-842b-3d338a795bcc
_version_ 1782228033916108800
collection PubMed
description
format Online
Article
Text
id pubmed-3313822
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-33138222012-03-29 Correction: Predicting Tumor Responses to Gefitinib and Erlotinib PLoS Med Correction Public Library of Science 2012-03-05 /pmc/articles/PMC3313822/ http://dx.doi.org/10.1371/annotation/d3542745-d656-445b-842b-3d338a795bcc Text en Public Library of Science. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Correction
Correction: Predicting Tumor Responses to Gefitinib and Erlotinib
title Correction: Predicting Tumor Responses to Gefitinib and Erlotinib
title_full Correction: Predicting Tumor Responses to Gefitinib and Erlotinib
title_fullStr Correction: Predicting Tumor Responses to Gefitinib and Erlotinib
title_full_unstemmed Correction: Predicting Tumor Responses to Gefitinib and Erlotinib
title_short Correction: Predicting Tumor Responses to Gefitinib and Erlotinib
title_sort correction: predicting tumor responses to gefitinib and erlotinib
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313822/
http://dx.doi.org/10.1371/annotation/d3542745-d656-445b-842b-3d338a795bcc
work_keys_str_mv AT correctionpredictingtumorresponsestogefitinibanderlotinib